Texas' has the highest rate of uninsured children, and it's getting worse
HOUSTON — Almost 1 million Texas children and teens went without health insurance at some point over the most recent year recorded. Many of them live in Houston, which has a higher rate of uninsured children than any other major metropolitan area in the nation.
Overall, Texas has the worst coverage rate for kids in the country, with nearly 12% going uninsured in 2023 — up from nearly 11% in 2022.
A number of issues are driving the numbers. But the fact that many uninsured Texas children are actually eligible for public insurance exposes what experts say are alarming gaps in the state's enrollment and outreach system — gaps that can limit health-care access for low-income kids and endanger their health.
Among the issues is a backlog of thousands of families who applied for Medicaid or the Children's Health Insurance Program, known as CHIP. For most of 2024, the average waiting time for a decision by the state was well over two months, which triggered a federal probe under the Biden administration. The application process remains tedious and confusing, requiring families to sometimes round up dozens of documents to prove they're eligible. Some give up.
The state has booted more than 1 million children from Medicaid since it began reviewing recipients' eligibility again in 2023 after a pause during the COVID-19 pandemic. Many were dropped not because they were ineligible, but for procedural reasons, such as their parents' failure to submit a renewal packet.
Texas lawmakers also have rejected or stalled proposals that typically help more children access CHIP or Medicaid. A 2023 state House bill would have streamlined Medicaid and CHIP enrollment for kids by relying on information already verified via other state benefit programs, such as food assistance. Despite bipartisan support, the bill failed to advance. It's been introduced again in this year's session.
Texas has shunned broad proposals enacted by other states, such as expanding Medicaid for low-income adults. Research shows Medicaid expansion has a 'welcome-mat' effect for children, with parents on Medicaid more likely to sign up their eligible kids as well.
The range of barriers mean many Texas children go without vital medical care or health screenings, health experts and advocates say.
'When kids are enrolled in Medicaid, they do have better access and better health care outcomes,' said Alec Mendoza, senior policy associate for health at Texans Care for Children.
Until recently, Houston native Maria Reyes was terrified that her 7-year-old daughter, Maya, might join the ranks of Texas' uninsured. No child should miss out on regular medical checkups, but Maya really can't.
She was born with a rare genetic condition that prevents her pancreas from properly absorbing nutrients and her bone marrow from producing enough blood cells. As a baby, she couldn't put on weight and her breathing was erratic, a symptom of rib-cage abnormalities caused by the condition, known as Shwachman-Diamond syndrome. After multiple hospitalizations, she was diagnosed at 8 months old.
Maya needs frequent care to stay healthy, including visits with a blood specialist every two months and a bone marrow biopsy every year, Reyes said.
Without Texas Medicaid coverage, which Maya has had since she was a baby, the family would be swimming in medical debt, Reyes said. Just one of her prescriptions costs about $1,500 a month.
Reyes was braced for that reality last fall when the state conducted its yearly assessment of Medicaid eligibility for Maya and her two younger siblings. She was worried that her new job as a medical assistant, making less than $20 an hour, might bump her income enough to disqualify her kids. While the family could visit a local community health center that serves the uninsured, finding affordable specialty care would be very difficult.
She spent weeks trying to prove their eligibility. 'It's like they don't believe you need it,' she said.
Maya has more complex medical needs than most kids. But research shows that going without health insurance has serious risks for all children, particularly in their early years, when their bodies are still developing and they're vulnerable to infections.
In interviews with Public Health Watch, health providers and advocates in Houston said their experiences mirror what the research already reports: Uninsured children are more likely to have unmet health-care needs. As a result, their families, who typically have low incomes, face more financial stress.
The number of Texas kids who are eligible for public insurance but not signed up is especially frustrating, advocates said. A 2023 report from Texas 2036, a public-policy nonprofit, estimated that 400,000 uninsured Texas children were eligible for Texas Medicaid or CHIP but weren't enrolled.
For Reyes, her hunch about her kids' Medicaid coverage wasn't totally off. Maya was still eligible, but to keep all three of her children covered and healthy, Reyes had to cut her work hours.
In April 2023, states began dropping people from Medicaid rolls when federal pandemic protections came to an end. Texas disenrolled 2.5 million people by September 2024 — the most of any state, according to a Kaiser Family Foundation tracker of the Medicaid 'unwinding.' A year after it began, more than 1.3 million Texas kids had lost their Medicaid coverage, most of them for procedural reasons, Texas Human Health and Services Commission reported.
While community health centers can still serve as medical homes for the uninsured, parents of uninsured kids are often less likely to bring them in for care, said Jana Eubank, executive director of the Texas Association of Community Health Centers. They are often worried about incurring unexpected bills they can't pay.
'If they need specialty care or inpatient care, they often just go without or wait until it's very serious and present at the emergency room,' she said.
Regular checkups for kids are vital. They give doctors a chance to catch developmental delays early, such as low weight gain or trouble walking and talking.
In the first two years of life, the American Academy of Pediatrics recommends that children visit with their physicians nearly a dozen times.
Years of research show that people with health insurance, including kids, are more likely to access preventive care and receive medical treatments they need. One study, published in 2017, followed a group of 237 children in Dallas County who were eligible for Medicaid or CHIP. Researchers found that uninsured children were almost four times more likely than insured ones to have no primary care provider and three times more likely to delay or skip needed health or dental care.
With Medicaid or CHIP, families rarely have out-of-pocket costs, said pediatrician D. Maneesh Kumar, who runs a small practice in Southwest Houston. About 70% of his patients rely on public insurance. 'It's actually really good coverage,' he said.
But for uninsured kids in households with few resources, even minor medical needs — like treatment for an ear infection or head lice — can be a financial strain, said Dr. Kavon Young, chief clinical officer at El Centro de Corazón, a community health center with three clinics in East Houston. About 40% of its 5,500 pediatric patients are uninsured.
'Something very simple for a child who's insured can pose a lot of difficulty for a child who is not,' Young said.
The health center can offer families low-cost primary care for their uninsured kids, but parents have far fewer, if any, affordable options if their child needs more complex medical care.
Keren, who asked that only her first name be used, has been bringing her three young children to El Centro de Corazón for the last year. All three are uninsured, she said last fall through an interpreter, but the clinic offers a sliding-scale rate she can afford.
She said at times it can be stressful to cover the costs, especially for her children's dental work. But she said she is nervous about filling out the paperwork to apply for Medicaid or CHIP.
Providers and advocates say parents' hesitancy is one reason so many Texas children remain uninsured despite being eligible for state coverage. Some parents are confused by the application process; still others have tried and been rejected for procedural reasons.
Then there are the huge backlogs at the state level in reviewing Medicaid and CHIP applications.
One of the biggest impediments to enrolling eligible kids is the current 'political environment around immigration,' said Marcie Mir, CEO of El Centro de Corazón, referring to state and federal policies, such as Gov. Greg Abbott's 2024 order requiring public hospitals to collect information about undocumented immigrants who seek treatment.
Even if their children do qualify, many immigrant parents don't want to draw any attention from government officials, Mir said. Nearly half of Houston children are in a household with at least one immigrant parent, according to a 2023 report.
The checklist that Maricela Delcid gives parents wanting Texas Medicaid for their kids is long and tedious: Social Security cards, birth certificates, lease contracts, child support records, utility bills, bank statements and two months of detailed income verification. The paper application is 33 pages.
Delcid is team leader for benefits assistance at Epiphany Community Health Outreach Services, or ECHOS, a Houston nonprofit that helps residents apply for public programs like Medicaid. Last year, the nonprofit assisted with about 1,400 applications for Medicaid or food assistance. Many of them families with mixed eligibility status, meaning parents might not be eligible for assistance but their children are.
Delcid is well acquainted with the Texas online benefits portal. She whips around the site with her mouse and keyboard, peppering clients with questions as she helps them apply. The system is confusing to most, she said, especially those who aren't proficient in English or computer use.
The Medicaid application process confuses even medical students who visit the nonprofit to learn about challenges their clients face, said Cathy Moore, ECHOS' executive director.
'We can all hear about it, but until you see how difficult it is, you don't know,' she said.
On top of the application process, the waiting period for a decision can take many weeks longer than it should.
The bottleneck became so bad at one point that some families stopped trying, even though their kids were eligible, Delcid said.
In mid-September, the median statewide wait time for an eligibility determination for Medicaid was 83 days, state officials reported — longer than the 45-day federal limit. Delcid said that at one point last summer, the wait time reached more than 90 days. 'I'd never seen anything like that,' Moore said.
As of Jan. 31, more than 244,000 applications for Texas Medicaid or CHIP were waiting to be processed, up from nearly 132,000 in late November, said Jennifer Ruffcorn, a spokesperson for the Texas Health and Human Services Commission. Applicants were waiting an average of 54 days for an answer.
The backlog has grown even after Texas HHSC dealt with major staffing shortages. By April last year, the agency had reduced its vacancy rate for eligibility advisers to 2.5%, down from over 21% in March 2022. As of November, Ruffcorn said the vacancy rate was about 3.5%.
The long waits prompted the U.S. Centers for Medicare and Medicaid Services, or CMS, to open an investigation into the backlog last May.
At ECHOS, Delcid said wait times are back to normal — no more than 45 days. But the delays have had a lasting impact, as it's hard to convince families who got caught up in the backlog to try again, she said.
When wait times were much longer, some kids were rejected and their families told to re-apply — not because they were ineligible, but because the information they had submitted was too old to process by the time they reached the front of the line.
At that point, some families give up, believing the system doesn't work, Delcid said. 'It gets to the point that they're hopeless. It's a story we kept seeing.'
Delcid and Moore said they suspect the children who remain uninsured see a doctor only when they're sick and don't get all the preventive care experts recommend. Their families also risk being saddled with medical bills they can't afford and that Medicaid would have covered.
In a statement to Public Health Watch in November about its investigation, CMS said it 'continues to be actively engaged to bring [Texas] into alignment with federal requirements.'
Emails to CMS earlier this month about the probe's status went unanswered. Ruffcorn at Texas HHSC confirmed the review was still ongoing.
When Congress reauthorized CHIP in 2009, it included a new option for states — "express lane eligibility' — that made it easier for eligible kids to get covered. But first state lawmakers had to adopt it.
In Texas, State Rep. John Bucy III, an Austin Democrat, sponsored a bill to create an express lane in the 2023 legislative session.
The bill passed the House with bipartisan support. It was even endorsed by leading conservative groups such as the Texas Public Policy Foundation, an opponent of Medicaid expansion. But it died in the state Senate, where it never got a hearing.
'Increasing access [to health coverage] is such an uphill fight here,' said Bucy, who has introduced the bill again in the current session.
As of 2021, seven states had an express lane for children's Medicaid; two had it for Medicaid and CHIP. The idea is that states use the information that families submit for other safety-net programs, such as the Supplemental Nutrition Assistance Program, to determine kids' eligibility for Medicaid or CHIP.
Bucy's bill requires parents' permission before an eligible child is enrolled in Medicaid. But families wouldn't have to endure another application process. Bucy said an express lane could reach hundreds of thousands of uninsured Texas kids who are eligible but unenrolled.
Research shows express lane laws for children have yielded significant coverage gains and administrative cost savings for states.
Alabama started express-lane eligibility in 2010 and has experienced such results, said pediatrician Marsha Raulerson, who is on the state's medical advisory committee for Medicaid. 'It's rare a child doesn't have access to health insurance here,' she said.
While Alabama has one of the country's worst child poverty rates, just under 4% of children there are uninsured — about a third of the Texas rate.
In Texas, newer technology and more eligibility workers would help fix the state's enrollment problems, the Texas HHSC said. In its 2026-2027 appropriations request, the agency wrote that without more funding, wait times for Medicaid applicants will 'continue to fluctuate' and Texas will be unable to fully comply with the 45-day federal standard.
State lawmakers have responded with budget bills in the Texas House and Senate that include the $300 million that HHSC requested to meet federal waiting-time rules, said Mendoza at Texans Care for Children. If approved, he said the funding would help Texas Medicaid streamline its enrollment process.
But in Congress, Republican proposals to cut federal Medicaid funding could dampen efforts to insure more low-income kids.
Children face the brunt of such cuts, said Edwin Park, a Medicaid researcher at Georgetown University's Center for Children and Families. As of October 2024, about 75% of Texas Medicaid's 3.8 million enrollees were kids.
'In Texas, it's mostly kids, seniors and people with disabilities on Medicaid,' Park said. 'That's where the cuts would hit. There isn't anywhere else.'
Most of the people who rely on Hope Clinic, a community health center with five clinics in Houston, are immigrants and refugees. Its patients speak more than 30 languages.
Dr. Andrea Caracostis, the clinic's CEO, said its staff is well versed in helping parents overcome application obstacles to Medicaid and CHIP enrollment for their kids. In Texas, children who are lawfully in the country are eligible for the programs.
But misinformed fears that applying will hurt a family's immigration status persist and are a major reason children remain uninsured, Caracostis said.
'I have patients that I beg — I say 'Please get on Medicaid. You have a complicated pregnancy, anything can happen, you're going to rack up debt,'' Caracostis said. 'And they won't … They're afraid of being perceived as a public charge.'
Under federal law, people deemed likely to become dependent on public assistance can be denied lawful permanent residence.
The policy doesn't include Medicaid, but that changed under the first Trump administration. Biden rescinded the change, but policy experts expect it to return during Trump's second term.
While Trump's public charge change never applied to children, Caracostis said many parents remain confused and afraid to enroll anyone in the family.
According to Every Texan, fears about accessing public services in immigrant communities was likely the main reason for a 237,000 decline in children in Texas Medicaid and CHIP from December 2017 to February 2020.
Caracostis expects those fears to roar back. 'There are lives at stake,' she said.
This story is part of 'Uninsured in America,' a project led by Public Health Watch that focuses on life in America's health coverage gap and the 10 states that haven't expanded Medicaid under the Affordable Care Act. Public Health Watch is a nonprofit, investigative news organization based in Texas.
Disclosure: Texans Care for Children, Texas 2036, Texas Association of Community Health Centers and Texas Public Policy Foundation have been financial supporters of The Texas Tribune, a nonprofit, nonpartisan news organization that is funded in part by donations from members, foundations and corporate sponsors. Financial supporters play no role in the Tribune's journalism. Find a complete list of them here.
We can't wait to welcome you to the 15th annual Texas Tribune Festival, Texas' breakout ideas and politics event happening Nov. 13–15 in downtown Austin. Step inside the conversations shaping the future of education, the economy, health care, energy, technology, public safety, culture, the arts and so much more.
Hear from our CEO, Sonal Shah, on TribFest 2025.
TribFest 2025 is presented by JPMorganChase.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Politico
35 minutes ago
- Politico
Troops deployed to LA will cost $134M, Pentagon official says
President Donald Trump's decision to deploy troops to Los Angeles amid mass deportation protests will likely cost $134 million, the Pentagon's budget chief told lawmakers. Acting Pentagon comptroller Bryn MacDonnell, testifying at a House budget hearing on Tuesday alongside Defense Secretary Pete Hegseth, said the estimate covers costs such as travel, housing and food. Trump has ordered 4,000 National Guard members and 700 Marines to Los Angeles to assist law enforcement with the protests, although California Gov. Gavin Newsom and Los Angeles Mayor Karen Bass have said they are not needed. Hegseth sparred with Democrats during the hearing in defense of the deployment, arguing Newsom and Bass, both Democrats, mishandled the situation.

Epoch Times
42 minutes ago
- Epoch Times
Wisconsin Breaks From CDC, Keeps COVID-19 Vaccine Recommendation for Pregnant Women
Wisconsin's health department is keeping in place its recommendation that pregnant women and all children receive one of the currently available COVID-19 vaccines, diverging from guidance by the Centers for Disease Control and Prevention. The Wisconsin Department of Health Services
Yahoo
43 minutes ago
- Yahoo
Multi-Blood Monitoring System Market is expected to reach USD 3.9 billion by 2034, with a 6.4% CAGR growth
Multi Blood Monitoring System Market Overview 2025-2034 Luton, Bedfordshire, United Kingdom, June 10, 2025 (GLOBE NEWSWIRE) -- The global multi blood monitoring system market is witnessing dynamic expansion, with its value estimated at approximately USD 2.1 billion in 2024, and expected to grow to around USD 3.9 billion by 2034. This translates into a Compound Annual Growth Rate (CAGR) of 6.4% over the forecast period from 2025 to 2034. This growth is primarily fueled by the increasing demand for accurate, efficient, and accessible blood monitoring technologies across various healthcare applications. Download PDF Brochure: These devices are critical in the management of chronic diseases such as diabetes and cardiovascular conditions. As the global burden of such illnesses escalates, particularly among aging populations and across developing regions, the need for real-time, portable, and user-friendly blood monitoring systems has become more urgent than ever. Market Drivers and Opportunities Several underlying factors are contributing to the expansion of this market. Among the most significant drivers is the rising prevalence of chronic diseases. The World Health Organization (WHO) forecasts that by 2030, chronic diseases will account for over 75% of global deaths, highlighting the growing necessity for continuous and reliable health monitoring tools. Moreover, technological advancements in wearable devices, mobile health apps, and telemedicine have revolutionized the way blood monitoring is conducted. These innovations have led to more personalized and preventive healthcare solutions, allowing patients to self-monitor in real-time, often without the need for clinical supervision. This trend is particularly appealing to tech-savvy consumers and younger demographics who are increasingly proactive about their health. Emerging economies also present significant growth potential. With rising healthcare expenditure, expanding middle-class populations, and improving medical infrastructure, regions such as Asia-Pacific, Latin America, and parts of the Middle East are becoming fertile grounds for market expansion. Additionally, the integration of AI and machine learning into monitoring systems is creating opportunities for predictive diagnostics and tailored treatment strategies, revolutionizing the future of personalized medicine. Key Market Challenges Despite its positive growth outlook, the multi blood monitoring system market faces certain challenges. One of the primary obstacles is the complex regulatory landscape. Medical device manufacturers must navigate stringent approval processes, especially in developed regions like North America and Europe. These regulations, although necessary for ensuring safety and efficacy, often delay product rollouts and increase development costs. Supply chain disruptions have also impacted the market, particularly during and after the COVID-19 pandemic. Delays in procuring raw materials, component shortages, and transportation hurdles have affected production timelines and product availability. Furthermore, high costs associated with technologically advanced blood monitoring devices can be a deterrent for adoption, especially in price-sensitive markets. Healthcare providers are often pressured to deliver cost-effective solutions, which can limit investments in premium monitoring systems. Another pressing concern is data security and patient privacy. With the growing digitalization of healthcare and increased reliance on cloud-based data storage, ensuring the protection of sensitive patient information has become paramount. Regulatory frameworks such as HIPAA and GDPR are placing additional burdens on companies to fortify their cybersecurity measures. Market Segmentation Analysis By Product Type The market is segmented into several product categories including continuous glucose monitoring (CGM) systems, blood pressure monitors, cholesterol testing devices, and complete blood count (CBC) test devices. Among these, CGM systems are emerging as the dominant product category, accounting for roughly 35% of market share. The increased prevalence of diabetes globally has significantly contributed to this trend. Blood pressure monitoring devices come in second, capturing an estimated 25% of the market, owing to the widespread incidence of hypertension. Cholesterol testing devices follow with a 15% market share, as more individuals become aware of the risks associated with high cholesterol levels. By End User Hospitals are the largest consumers of multi blood monitoring systems, accounting for nearly 45% of the market share. The growing number of patients and a strong focus on preventive healthcare are driving demand in this segment. Diagnostic laboratories represent the second-largest user group, contributing 30% of market revenue, largely due to the complexity and volume of testing they handle. Homecare settings have gained traction, especially post-pandemic, and currently hold around 20% of the market. The convenience of remote monitoring has been widely appreciated, particularly among the elderly and chronically ill patients who prefer in-home testing. By Technology From a technology standpoint, wearable technologies are transforming the landscape, projected to represent 40% of the market by 2034. These devices offer unmatched convenience and user engagement. Invasive technologies still maintain a solid 45% market share, particularly in clinical environments where precision is critical. Meanwhile, non-invasive technologies are growing steadily and are expected to hold 15% of the market, driven by advancements in optical and sensor-based innovations. By Application Diabetes management remains the top application area, constituting about 50% of the total market. As diabetes rates continue to climb worldwide, the demand for continuous and accurate glucose monitoring devices is increasing proportionally. Cardiovascular monitoring is another important application, making up 30% of the market, while fitness and wellness monitoring is growing rapidly, accounting for around 15% as consumers adopt proactive health strategies. By Distribution Channel In terms of distribution, offline sales still dominate with a 55% market share, primarily due to the preference for in-person consultations and product demonstrations in hospital and clinical settings. Online channels, however, are growing fast and now represent 30% of sales, fueled by digital adoption and e-commerce growth. Direct sales—through specialized distributors—comprise the remaining 15%, ensuring product customization and support services. Browse full Report - Market Segmentation Product Type - Continuous Glucose Monitoring Systems - Blood Pressure Monitoring Devices - Cholesterol Testing Devices - Complete Blood Count Test Devices - Others End-User - Hospitals - Diagnostic Laboratories - Homecare Settings - Research Institutions Technology - Wearable Technology - Non-invasive Technology - Invasive Technology Application - Diabetes Management - Cardiovascular Monitoring - Blood Disorders Management - Fitness and Wellness Monitoring Distribution Channel - Online Sales - Offline Sales - Direct Sales Region - North America - Europe - Asia Pacific - Latin America - Middle East & Africa Regional Outlook Regionally, North America leads the global market, accounting for approximately 40% of total revenues in 2024. This dominance is attributed to advanced healthcare infrastructure, favorable regulatory support, and the presence of leading industry players. Europe follows with a 30% market share, supported by robust public healthcare systems and a rising focus on personalized medicine. The Asia-Pacific region is the fastest-growing market, projected to expand at a CAGR of 7.5%. This growth is driven by large patient populations, increasing disposable income, and government initiatives to enhance healthcare access. Countries such as China, India, and Japan are key contributors to this growth trajectory. Latin America and the Middle East & Africa collectively account for a modest share (5% in 2024) but are poised for steady growth due to improvements in healthcare infrastructure and expanding awareness about chronic disease management. Key Competitors Abbott Laboratories Roche Holding AG Siemens Healthineers Becton, Dickinson and Company (BD) Medtronic plc Nova Biomedical Johnson & Johnson Dexcom, Inc. Arkray, Inc. Ascensia Diabetes Care Terumo Corporation GlySens Incorporated Insulet Corporation Elysium Health LabCorp Recent Industry Developments Several companies have made notable strides in advancing this market: Abbott Laboratories launched FreeStyle Libre 3, a real-time glucose monitor with a discreet sensor, in June 2023, strengthening its lead in the CGM space. In April 2023, Roche formed a strategic partnership with a wearable tech firm to integrate blood monitoring devices with smart devices, enhancing patient engagement and adherence. Siemens Healthineers acquired an AI-based diagnostics company in August 2023, signaling a deeper focus on precision diagnostics through data analytics. Dexcom received FDA approval in September 2023 for a no-fingerstick CGM device, which is likely to broaden its user base and redefine market standards. Medtronic expanded its product line into Asia and Africa in July 2023, targeting underserved markets and accelerating growth in emerging economies. This report is also available in the following languages : Japanese (マルチ血液モニタリングシステム市場), Korean (다혈액 모니터링 시스템 시장), Chinese (多血液监测系统市场), French (Marché des systèmes de surveillance sanguine multi-sang), German (Markt für Multi-Blutüberwachungssysteme), and Italian (Mercato dei sistemi di monitoraggio multi-sangue), etc. Request Sample Pages: More Research Finding – Medical Refrigerated Market The global medical refrigerated market is valued at approximately $6.5 billion in 2024, with projections indicating a potential increase to around $10 billion by 2034. This growth reflects a robust Compound Annual Growth Rate (CAGR) of approximately 4.5% during the forecast period from 2025 to 2034. Cardiovascular Monitoring Devices Market The cardiovascular monitoring devices market is valued at approximately $10.5 billion in 2024, with projections indicating substantial growth, reaching around $16.8 billion by 2034. This translates to a robust Compound Annual Growth Rate (CAGR) of approximately 4.8% during the forecast period from 2025 to 2034. Non Invasive Hemodynamic Detection System Market The global Non-Invasive Hemodynamic Detection System market is valued at approximately USD 2.1 billion in 2024, with strong growth anticipated over the next decade. By 2034, the market is projected to reach around USD 4.5 billion, representing a Compound Annual Growth Rate (CAGR) of approximately 8.0%. Disposable Syringes and Accessories Market The global disposable syringes and accessories market is valued at approximately $7.5 billion in 2024, with a projected growth trajectory that anticipates reaching around $13 billion by 2034. This translates to a compound annual growth rate (CAGR) of about 6.1% over the 2025-2034 period. Blood Collection Mixer Market The blood collection mixer market is valued at approximately $250 million in 2024 and is projected to reach around $400 million by 2034. This growth represents a Compound Annual Growth Rate (CAGR) of about 5.1% during the forecast period from 2025 to 2034. Hemochromatosis Treatment Market The global hemochromatosis treatment market is valued at approximately $2.1 billion in 2024. The market is anticipated to grow significantly, reaching an estimated $3.5 billion by 2034, reflecting a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period of 2025–2034. Gestational Trophoblastic Disease Market The gestational trophoblastic disease (GTD) market is currently valued at approximately $1.8 billion in 2024, with projections indicating a potential growth to around $3.1 billion by 2034. This represents a compound annual growth rate (CAGR) of approximately 6.2% during the forecast period from 2025 to 2034. Septicemia Diagnostic Market The global septicemia diagnostics market is valued at approximately $1.5 billion in 2024, with projections indicating a growth to around $2.9 billion by 2034. This represents a Compound Annual Growth Rate (CAGR) of about 7.5% for the period from 2025 to 2034. Single Use Safety Lancet Market The global market for single-use safety lancets, valued at approximately $1.2 billion in 2024, is expected to reach around $2.5 billion by 2034, reflecting a robust Compound Annual Growth Rate (CAGR) of 7.7% during the forecast period from 2025 to 2034. Microalbuminuria Test Strip Market The microalbuminuria test strip market is poised for notable growth, valued at approximately $1.2 billion in 2024. This market is projected to expand to around $2.4 billion by 2034, indicating a robust growth trajectory. The Compound Annual Growth Rate (CAGR) for the forecast period from 2025 to 2034 is estimated at 7.3%. Monkeypox Virus Detection Reagent Market The monkeypox virus detection reagent market is anticipated to reach approximately $150 million in value by 2024, driven by heightened awareness and diagnostic needs amid ongoing public health surveillance. The market is projected to expand significantly, reaching an estimated $300 million by 2034, reflecting sustained interest in infectious disease diagnostics and preparedness. Blood Tester Market The global blood testing market is anticipated to reach a value of approximately $75 billion in 2024, driven by increasing prevalence of chronic diseases, rising health awareness, and advancements in diagnostic technologies. The market is projected to grow at a Compound Annual Growth Rate (CAGR) of 6.5% from 2025 to 2034, potentially reaching over $135 billion by 2034. HBsAg ELISA Test Kit Market The HBsAg ELISA Test Kit market is poised for robust growth, with a current market value estimated at approximately $1.5 billion in 2024. Driven by the increasing global prevalence of Hepatitis B, ongoing advancements in diagnostic technologies, and rising healthcare expenditures, the market is projected to reach around $2.8 billion by 2034. This trajectory indicates a Compound Annual Growth Rate (CAGR) of approximately 6.5% from 2025 to 2034. Blood Plasma Extractor Market The global blood plasma extractor market is valued at approximately $1.2 billion, driven by rising demand for plasma-derived therapies in treating various diseases. The market is projected to reach about $2.9 billion by 2034, reflecting an impressive Compound Annual Growth Rate (CAGR) of approximately 9.2% from 2025 to 2034. Amphetamine Test Kit Market The amphetamine test kit market is projected to reach a value of approximately $500 million in 2024, with expectations to grow to around $900 million by 2034. This growth reflects a robust Compound Annual Growth Rate (CAGR) of 6% during the forecast period of 2025 to 2034. CONTACT: Irfan Tamboli (Head of Sales) Phone: + 1704 266 3234 Email: sales@ in to access your portfolio